Given its role in maintaining cellular homeostasis, the UPR presents an attractive target for therapeutic intervention. Modulating UPR pathways could potentially mitigate the effects of toxicants and treat diseases associated with ER stress. Agents that enhance the adaptive phase of the UPR or inhibit its apoptotic phase are being explored for therapeutic use.
